Quest Diagnostics SVP acquires 46 shares at $189.079 (Form 4)

Quest Diagnostics (DGX) reported an insider transaction by its SVP for Diagnostic Services.

Rhea-AI Filing Summary

Quest Diagnostics (DGX) reported an insider transaction by its SVP for Diagnostic Services. On 10/21/2025, the officer acquired 46 shares of common stock at $189.079, as noted in a footnote describing purchases via a dividend reinvestment plan eligible for deferred reporting under Rule 16a-6 but reported early. Following this, direct beneficial ownership stood at 15,333 shares.

Insider Trade Summary

Grant/Award: 46 shares

Grant/Award 1 txn

Insider Plewman Patrick

Role SVP for Diagnostic Services

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	46	$189.079	$9K

Holdings After Transaction: Common Stock — 15,333 shares (Direct)

Footnotes (2)

1. F1. Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
2. F2. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did DGX report on Form 4?

An SVP for Diagnostic Services acquired 46 common shares on 10/21/2025 at $189.079 per share.

What is the DGX insider’s total direct holdings after the transaction?

Direct beneficial ownership is 15,333 shares following the reported transaction.

How were the DGX shares acquired?

A footnote states the shares were acquired via a dividend reinvestment plan eligible for deferred reporting under Rule 16a-6, but reported early.

What is the insider’s role at Quest Diagnostics (DGX)?

The reporting person is an Officer, serving as SVP for Diagnostic Services.

What ownership form is indicated for the DGX shares?

The filing lists Direct (D) ownership of the reported holdings.

Does the filing mention other share purchases?

A footnote says the amount includes exempt purchases made under the Company’s stock purchase plan since the last filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/24/2025 - 06:11 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plewman Patrick

(Last) (First) (Middle)

500 PLAZA DRIVE

C/O QUEST DIAGNOSTICS INC

(Street)

SECAUCUS NJ 07094

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUEST DIAGNOSTICS INC [ DGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP for Diagnostic Services

3. Date of Earliest Transaction (Month/Day/Year)
10/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/21/2025		A	V	46(1)	A	$189.079	15,333(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

2. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Remarks:

	Sean D. Mersten, Attorney in Fact for Patrick Plewman	10/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.